Alphatec Holdings Inc
$ 11.10
2.59%
17 Apr - close price
- Market Cap 1,680,059,000 USD
- Current Price $ 11.10
- High / Low $ 11.43 / 10.97
- Stock P/E N/A
- Book Value 0.08
- EPS -0.96
- Next Earning Report 2026-05-07
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.05 %
- ROE -6.31 %
- 52 Week High 23.29
- 52 Week Low 10.11
About
Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.
Analyst Target Price
$24.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-24 | 2025-10-30 | 2025-07-29 | 2025-05-05 | 2025-02-25 | 2024-10-30 | 2024-07-31 | 2024-05-07 | 2024-02-27 | 2023-11-06 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 0.06 | 0.03 | 0.02 | -0.0879 | -0.0638 | -0.28 | -0.29 | -0.34 | -0.37 | -0.35 | -0.43 | -0.4 |
| Estimated EPS | 0.0375 | -0.04 | -0.0622 | -0.1493 | -0.0375 | -0.25 | -0.28 | -0.31 | -0.25 | -0.28 | -0.28 | -0.31 |
| Surprise | 0.0225 | 0.07 | 0.0822 | 0.0614 | -0.0263 | -0.03 | -0.01 | -0.03 | -0.12 | -0.07 | -0.15 | -0.09 |
| Surprise Percentage | 60% | 175% | 132.1543% | 41.1253% | -70.1333% | -12% | -3.5714% | -9.6774% | -48% | -25% | -53.5714% | -29.0323% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-07 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.15 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ATEC
2026-04-18 06:39:35
Alphatec Holdings, Inc. (NASDAQ:ATEC) has received a consensus "Moderate Buy" rating from twelve analysts, with an average 12-month price target of $22.82. The medical technology company recently reported strong quarterly earnings, beating EPS and revenue estimates, though analysts still anticipate a full-year EPS of -1.08. Insiders have sold a significant number of shares recently, amounting to $9.18 million, while institutional investors have increased their positions.
2026-04-15 11:39:34
Stifel has reiterated its "Buy" rating on Alphatec Holdings (ATEC). This indicates the firm's continued positive outlook on the company's stock performance. Investors will likely view this reiteration as a signal of confidence from the analyst community.
2026-04-12 05:09:58
This article states that HC Wainwright & Co. has maintained its "Buy" recommendation for Alphatec Holdings (ATEC). The content provided is minimal, only indicating the analyst firm's rating.
2026-04-12 05:09:27
HC Wainwright & Co. has reiterated its Buy rating for Alphatec Holdings (ATEC). The firm maintains a positive outlook on the company's stock.
2026-04-09 21:42:14
Alphatec Holdings, Inc.'s General Counsel, Marshall Tyson Eliot, exercised 102,500 employee stock options on April 7, 2026, in a cashless transaction. This resulted in a net acquisition of 79,107 shares after 23,393 shares were withheld to cover exercise prices, bringing his direct holdings to 638,566 shares. The event is characterized as a routine equity compensation exercise rather than a market sale.
2026-04-06 07:40:09
Aberdeen Group plc significantly increased its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 29.7% in Q4, acquiring an additional 294,792 shares, bringing their total to 1,286,195 shares valued at $27.06 million. Despite substantial insider selling amounting to $9.18 million from executives including the General Counsel and COO, Alphatec reported an earnings beat with Q4 EPS of $0.06 against an expected $0.04 and revenue up 20.4% year-over-year. Analysts currently hold a "Moderate Buy" consensus rating with an average price target of $22.82 for the medical technology company.
